Structural MRI correlates for vulnerability and resilience to major depressive disorder
Authors:
- Francesco AmicoFAFrancesco Amico
- Eva MeisenzahlEMEva Meisenzahl
- Nicolaos KoutsoulerisNKNicolaos Koutsouleris
- Maximilian ReiserMRMaximilian Reiser
- Hans-Juergen MöllerHMHans-Juergen Möller
- Thomas FrodlTFThomas Frodl
- 1 January 2011
- journal article
- Published by Canadian Science Publishing in Journal of Psychiatry and Neuroscience
- Vol. 36 (1) , 15-22
Abstract
In major depressive disorder (MDD), it is unclear to what extent structural brain changes are associated with depressive episodes or represent part of the mechanism by which the risk for illness is mediated. The aim of this study was to investigate whether structural abnormalities are related to risk for the development of MDD. We compared healthy controls with a positive family history for MDD (HC-FHP), healthy controls with no family history of any psychiatric disease (HC-FHN) and patients with MDD. Groups were age- and sex-matched. We analyzed data from high-resolution magnetic resonance imaging using voxel-based morphometry. We performed small volume corrections for our regions of interest (hippocampus, dorsolateral [DLPFC] and dorsomedial prefrontal cortex [DMPFC], anterior cingulate cortex [ACC] and basal ganglia) using a family-wise error correction (p < 0.05) to control for multiple comparisons. There were 30 participants in the HC-FHP group, 64 in the HC-FHN group and 33 patients with MDD. The HC-FHP group had smaller right hippocampal and DLPFC grey matter volumes compared with the HC-FHN group, and even smaller right hippocampal volumes compared with patients with MDD. In addition, the HC-FHP group exhibited smaller white matter volumes in the DLPFC and left putamen but also greater volumes in 2 areas of the DMPFC compared with the HC-FHN group. Patients with MDD exhibited smaller volumes in the ACC, DMPFC, DLPFC and the basal ganglia compared with healthy controls. The retrospective identification of family history might result in a bias toward unidentified participants in the control group at risk for MDD, diminishing the effect size. Volume reductions in the hippocampus and DLPFC might be associated with a greater risk for MDD. The HC-FHP group had smaller hippocampal volumes compared with patients with MDD, which is suggestive for neuroplastic effects of treatment. The HC-FHP group had not yet experienced a depressive episode and therefore might have been resilient and might have had some protective strategies. Whether resilience is associated with the larger white matter volumes in the DMPFC (e.g., owing to compensatory, neuroplastic remodelling mechanisms) needs to be confirmed in future studies.Keywords
This publication has 59 references indexed in Scilit:
- Neuroimaging genetics: new perspectives in research on major depression?Acta Psychiatrica Scandinavica, 2008
- Requirement of Hippocampal Neurogenesis for the Behavioral Effects of AntidepressantsScience, 2003
- Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT GeneScience, 2003
- An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data setsNeuroImage, 2003
- Course of illness, hippocampal function, and hippocampal volume in major depressionProceedings of the National Academy of Sciences, 2003
- Linking reward expectation to behavior in the basal gangliaTrends in Neurosciences, 2003
- Neurobiology of DepressionNeuron, 2002
- Volumetric reduction in left subgenual prefrontal cortex in early onset depressionBiological Psychiatry, 2002
- Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject BrainNeuroImage, 2002
- A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human BrainsNeuroImage, 2001